IART logo

Integra LifeSciences Holdings Corporation (IART)

$17.37

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on IART

Market cap

$1.35B

EPS

-6.47

P/E ratio

--

Price to sales

0.81

Dividend yield

--

Beta

1.216503

Price on IART

Previous close

$17.07

Today's open

$17.19

Day's range

$17.19 - $17.78

52 week range

$8.70 - $20.49

Profile about IART

CEO

Stuart Essig

Employees

4396

Headquarters

Princeton, NJ

Exchange

Nasdaq Global Select

Shares outstanding

77772506

Issue type

Common Stock

IART industries and sectors

Healthcare

Medical Equipment & Supplies

News on IART

Here's Why Integra LifeSciences (IART) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

news source

Zacks Investment Research • Aug 5, 2026

news preview

Integra LifeSciences Q2 Earnings Call Highlights

Integra LifeSciences NASDAQ: IART reported second-quarter 2026 revenue of $419 million, up 0.8% on a reported basis and 0.7% organically from a year earlier, as improving supply reliability and operational execution supported results. Adjusted earnings per share rose 24% year over year to $0.56, exceeding the company's guidance range.

news source

MarketBeat • Jul 29, 2026

news preview

Integra LifeSciences Holdings Corporation (IART) Q2 2026 Earnings Call Transcript

Integra LifeSciences Holdings Corporation (IART) Q2 2026 Earnings Call Transcript

news source

Seeking Alpha • Jul 29, 2026

news preview

Integra LifeSciences Reports Second Quarter 2026 Financial Results

PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2026.

news source

GlobeNewsWire • Jul 29, 2026

news preview

Integra LifeSciences (IART) Q2 Earnings Top Estimates

Integra LifeSciences (IART) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.45 per share a year ago.

news source

Zacks Investment Research • Jul 29, 2026

news preview

Integra (IART) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Integra (IART) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

news source

Zacks Investment Research • Jul 29, 2026

news preview

3 Stocks Showing Breakout Potential Ahead of August

Breakout stocks BSET, AVAH and IART are trading near 52-week highs after passing technical screens. See why they could outperform in August.

news source

Zacks Investment Research • Jul 29, 2026

news preview

Here's Why Integra LifeSciences (IART) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

news source

Zacks Investment Research • Jul 28, 2026

news preview

Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating Integra LifeSciences Holdings Corp. (NASDAQ: IART) (“Integra”) on behalf of the company's long-term investors. Click here for additional information: https://kaskelalaw.com/cases/integra-lifesciences/ Recently a securities fraud complaint was filed against Integra on behalf of investors who purchased shares of the company's stock between March 11, 2019 and May 22, 2023 (the “Wrongdoing Period”.

news source

Business Wire • Jul 23, 2026

news preview

IART vs. SONVY: Which Stock Is the Better Value Option?

Investors interested in Medical - Instruments stocks are likely familiar with Integra LifeSciences (IART) and SONOVA HOLDING (SONVY). But which of these two stocks is more attractive to value investors?

news source

Zacks Investment Research • Jul 22, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Integra LifeSciences Holdings Corporation

Open an M1 investment account to buy and sell Integra LifeSciences Holdings Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in IART on M1